Dendritic cell immunotherapy

BIOLOGICAL7 trials

Sponsors

Northwest Biotherapeutics, George Albert Fisher, Cedars-Sinai Medical Center, University Hospital, Ghent, PT. JES Kasih Nusantara Sejahterah

Conditions

Brain CancerBrain TumorDiabetic Kidney Disease (DKD)GBMGlioblastomaGlioblastoma MultiformeGliomaGrade IV Astrocytoma

Phase 1

Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer

CompletedNCT00547144

George Albert FisherPancreatic Cancer

Start: 2005-10-31End: 2008-04-30Updated: 2012-11-08

MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer

CompletedNCT04078269

University Hospital, GhentNon-small Cell Lung Cancer

Start: 2019-08-26End: 2025-03-03Updated: 2025-04-29

MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer

University Hospital, GhentNon-small Cell Lung Cancer Metastatic

Start: 2019-08-26End: 2021-12-31Updated: 2021-03-30

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Active, not recruitingNCT06866158

PT. JES Kasih Nusantara SejahterahDiabetic Kidney Disease (DKD)

Start: 2024-05-01End: 2026-08-05Updated: 2025-12-05

Phase 2

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

CompletedNCT00576537

Cedars-Sinai Medical CenterGlioblastoma

Start: 2001-03-31End: 2011-10-31Updated: 2019-05-03

Phase 3

Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.

WithdrawnNCT00043212

Northwest BiotherapeuticsProstate Cancer

Updated: 2013-05-01

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Northwest BiotherapeuticsBrain Cancer, Brain Tumor, GBM +4

Start: 2006-12-31Target: 348Updated: 2022-05-18

Related Papers

Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine

Advanced Science2025-03-262 citations

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

JAMA Oncology2022-11-17353 citations

Abstract withdrawn

2020-11-01

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

UNC Libraries2019-08-18

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

2018-05-29378 citations